FDA Research Fellowship: Neurodevelopmental Assessment of Prenatal Analgesic Exposure Using Translational Models

Research Project

NCTR is conducting developmental neurotoxicology studies at the request of CDER to assess a compound of particular regulatory importance. Findings from this research may directly inform guidelines on medication use during pregnancy.

Mentor

• John Talpos (john.talpos@fda.hhs.gov)
• Timothy Flanigan (timothy.flanigan@fda.hhs.gov)

Learning Objectives

• Gain hands-on experience with numerous methods used in neurotoxicological research including basic histology, immunohistochemistry, light and confocal microscopy, molecular biological techniques to assess gene expression and protein quantification, advanced behavioral assessments, and an introduction to magnetic resonance imaging.
• Gain practical experience in project organization, coordination, and execution.
• Present findings at internal and external meetings.
• Contribute to manuscript preparation.

Citizenship Requirements

• This opportunity is available to U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals.
• Non-U.S. citizen applicants should refer to the Guidelines for Non-U.S. Citizens Details page of the program website for information about the valid immigration statuses that are acceptable for program participation.

Qualifications

• Currently pursuing or have received a bachelor's, master's, or doctoral degree in relevant fields.
• Has received a bachelor’s or master’s degree within the past three years at the time of appointment, or has received or be currently pursuing a doctoral degree.
• I am a U.S. citizen, or I have lived in the United States for at least 36 out of the past 60 months.

Contact Information

• Email: ORISE.FDA.CDER@orau.org
• Reference Code: [Not specified]